230 related articles for article (PubMed ID: 12488299)
21. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
22. Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies.
Necchi A; Miceli R; Oualla K; Sonpavde G; Giannatempo P; Raggi D; Nicolai N; Boffi R; Busia A; Mariani L; Salvioni R
Clin Genitourin Cancer; 2017 Apr; 15(2):213-220.e5. PubMed ID: 27692810
[TBL] [Abstract][Full Text] [Related]
23. Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
den Hollander MW; Westerink ND; Lubberts S; Bongaerts AH; Wolf RF; Altena R; Nuver J; Oosting SF; de Vries EG; Walenkamp AM; Meijer C; Gietema JA
Oncologist; 2016 Aug; 21(8):995-1001. PubMed ID: 27328932
[TBL] [Abstract][Full Text] [Related]
24. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
25. Increased pulmonary FDG uptake in bleomycin-associated pneumonitis.
von Rohr L; Klaeser B; Joerger M; Kluckert T; Cerny T; Gillessen S
Onkologie; 2007 Jun; 30(6):320-3. PubMed ID: 17551256
[TBL] [Abstract][Full Text] [Related]
26. Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C
J Clin Oncol; 2018 Oct; 36(29):2950-2954. PubMed ID: 30156983
[TBL] [Abstract][Full Text] [Related]
27. [Probable pulmonary damage caused by bleomycin. Communication of 4 cases].
Arraztoa J; Oddó D; Cerda B; San Martin S
Rev Med Chil; 1991 Nov; 119(11):1270-6. PubMed ID: 9723079
[TBL] [Abstract][Full Text] [Related]
28. Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.
Thomas TS; Luo S; Reagan PM; Keller JW; Sanfilippo KM; Carson KR
J Geriatr Oncol; 2020 Jan; 11(1):69-74. PubMed ID: 31668826
[TBL] [Abstract][Full Text] [Related]
29. Bleomycin-related lung damage: CT evidence.
Bellamy EA; Husband JE; Blaquiere RM; Law MR
Radiology; 1985 Jul; 156(1):155-8. PubMed ID: 2408293
[TBL] [Abstract][Full Text] [Related]
30. The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomas.
Crooke ST; Einhorn LH; Comis RL; D'Aoust JC; Prestayko AW
Med Pediatr Oncol; 1978; 5(1):93-8. PubMed ID: 85253
[TBL] [Abstract][Full Text] [Related]
31. Risk of pulmonary toxicity of bleomycin and filgrastim.
Laprise-Lachance M; Lemieux P; Grégoire JP
J Oncol Pharm Pract; 2019 Oct; 25(7):1638-1644. PubMed ID: 30319063
[TBL] [Abstract][Full Text] [Related]
32. Bleomycin and scuba diving: where is the harm?
de Wit R; Sleijfer S; Kaye SB; Horwich A; Mead B; Sleijfer DT; Stoter G
Lancet Oncol; 2007 Nov; 8(11):954-5. PubMed ID: 17976605
[No Abstract] [Full Text] [Related]
33. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
34. Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK.
Watson RA; De La Peña H; Tsakok MT; Joseph J; Stoneham S; Shamash J; Joffe J; Mazhar D; Traill Z; Ho LP; Brand S; Protheroe AS
Br J Cancer; 2018 Oct; 119(9):1044-1051. PubMed ID: 30356125
[TBL] [Abstract][Full Text] [Related]
35. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
36. FELD better not thinking of metastases only when liver lesions appear after bleomycin-based treatment for non-seminoma testis from metastases.
De Vos FY; Mulder SF; Drenth JP; Nagtegaal ID; Fütterer JJ; van der Graaf WT
BMC Cancer; 2013 Oct; 13():491. PubMed ID: 24148527
[TBL] [Abstract][Full Text] [Related]
37. Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma.
van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Donker AJ; Meijer S; Schraffordt Koops H; Sluiter HJ; Peset R
Oncology; 1984; 41(1):4-7. PubMed ID: 6199706
[TBL] [Abstract][Full Text] [Related]
38. Primary chemotherapy for stage 2 testis cancer.
Abratt RP; McAdam GL; Pontin AR; Barnes RD; Ball HS
S Afr J Surg; 1997 Nov; 35(4):203-5; discussion 205-6. PubMed ID: 9540399
[TBL] [Abstract][Full Text] [Related]
39. The effect of concomitant use of Colony-Stimulating factors on bleomycin pulmonary toxicity - A systematic review and meta-analysis.
Mahdi Seyedzadeh Sani S; Sahranavard M; Jannati Yazdanabad M; Seddigh Shamsi M; Elyasi S; Hooshang Mohammadpour A; Sathyapalan T; Arasteh O; Ghavami V; Sahebkar A
Int Immunopharmacol; 2022 Nov; 112():109227. PubMed ID: 36099787
[TBL] [Abstract][Full Text] [Related]
40. The role of screening and monitoring for bleomycin pulmonary toxicity.
Shippee BM; Bates JS; Richards KL
J Oncol Pharm Pract; 2016 Apr; 22(2):308-12. PubMed ID: 25736276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
